296 related articles for article (PubMed ID: 7780983)
1. Mutations of the K-ras and p53 genes in gastric adenocarcinomas from a high-incidence region around Florence, Italy.
Hongyo T; Buzard GS; Palli D; Weghorst CM; Amorosi A; Galli M; Caporaso NE; Fraumeni JF; Rice JM
Cancer Res; 1995 Jun; 55(12):2665-72. PubMed ID: 7780983
[TBL] [Abstract][Full Text] [Related]
2. Alterations of the p53 tumor suppressor gene and its association with activation of the c-K-ras-2 protooncogene in premalignant and malignant lesions of the human uterine endometrium.
Enomoto T; Fujita M; Inoue M; Rice JM; Nakajima R; Tanizawa O; Nomura T
Cancer Res; 1993 Apr; 53(8):1883-8. PubMed ID: 8385572
[TBL] [Abstract][Full Text] [Related]
3. Comparison of mutations in the p53 and K-ras genes in lung carcinomas from smoking and nonsmoking women.
Gealy R; Zhang L; Siegfried JM; Luketich JD; Keohavong P
Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 1):297-302. PubMed ID: 10207632
[TBL] [Abstract][Full Text] [Related]
4. Diet, Helicobacter pylori, and p53 mutations in gastric cancer: a molecular epidemiology study in Italy.
Palli D; Caporaso NE; Shiao YH; Saieva C; Amorosi A; Masala G; Rice JM; Fraumeni JF
Cancer Epidemiol Biomarkers Prev; 1997 Dec; 6(12):1065-9. PubMed ID: 9419404
[TBL] [Abstract][Full Text] [Related]
5. K-ras and p53 mutations in stage I gallbladder carcinoma with an anomalous junction of the pancreaticobiliary duct.
Hanada K; Itoh M; Fujii K; Tsuchida A; Ooishi H; Kajiyama G
Cancer; 1996 Feb; 77(3):452-8. PubMed ID: 8630951
[TBL] [Abstract][Full Text] [Related]
6. p53, Ki-ras, and DNA ploidy in human pancreatic ductal adenocarcinomas.
Weyrer K; Feichtinger H; Haun M; Weiss G; Ofner D; Weger AR; Umlauft F; Grünewald K
Lab Invest; 1996 Jan; 74(1):279-89. PubMed ID: 8569192
[TBL] [Abstract][Full Text] [Related]
7. Analysis of p53 abnormalities in endoscopic gastric biopsies.
Imatani A; Sasano H; Asaki S; Toyota T; Saito M; Masuda T; Nagura H
Anticancer Res; 1996; 16(4A):2049-56. PubMed ID: 8712741
[TBL] [Abstract][Full Text] [Related]
8. Mutations of p53 gene in gastric carcinoma in Taiwan.
Wang JY; Lin SR; Hsieh JS; Hsu CH; Huang YS; Huang TJ
Anticancer Res; 2001; 21(1B):513-20. PubMed ID: 11299797
[TBL] [Abstract][Full Text] [Related]
9. p53 and RAS gene mutations in multiple myeloma.
Portier M; Molès JP; Mazars GR; Jeanteur P; Bataille R; Klein B; Theillet C
Oncogene; 1992 Dec; 7(12):2539-43. PubMed ID: 1461658
[TBL] [Abstract][Full Text] [Related]
10. K-ras mutations in gastric stump carcinomas and in carcinomas from the non-operated stomach.
van Rees BP; Musler A; Caspers E; Drillenburg P; Craanen ME; Polkowski W; Chibowski D; Offerhaus GJ
Hepatogastroenterology; 1999; 46(27):2063-8. PubMed ID: 10430398
[TBL] [Abstract][Full Text] [Related]
11. Genetic analysis of human esophageal tumors from two high incidence geographic areas: frequent p53 base substitutions and absence of ras mutations.
Hollstein MC; Peri L; Mandard AM; Welsh JA; Montesano R; Metcalf RA; Bak M; Harris CC
Cancer Res; 1991 Aug; 51(15):4102-6. PubMed ID: 1855226
[TBL] [Abstract][Full Text] [Related]
12. Mutation of H-ras is infrequent in bladder cancer: confirmation by single-strand conformation polymorphism analysis, designed restriction fragment length polymorphisms, and direct sequencing.
Knowles MA; Williamson M
Cancer Res; 1993 Jan; 53(1):133-9. PubMed ID: 8093230
[TBL] [Abstract][Full Text] [Related]
13. Usefulness of p53 gene mutations in the supernatant of bile for diagnosis of biliary tract carcinoma: comparison with K- ras mutation.
Wang Y; Yamaguchi Y; Watanabe H; Ohtsubo K; Wakabayashi T; Sawabu N
J Gastroenterol; 2002; 37(10):831-9. PubMed ID: 12424567
[TBL] [Abstract][Full Text] [Related]
14. Characterization of p53 gene mutations in colorectal carcinomas from an Asian population.
Shi CY; Phang TW; Ngoi SS; Wee A; Li B; Lin Y; Lee HP; Ong CN
Anticancer Res; 1994; 14(6B):2811-6. PubMed ID: 7872723
[TBL] [Abstract][Full Text] [Related]
15. Molecular diagnosis of p53 mutations in gastric carcinoma by touch preparation.
Ricevuto E; Ficorella C; Fusco C; Cannita K; Tessitore A; Toniato E; Gabriele A; Frati L; Marchetti P; Gulino A; Martinotti S
Am J Pathol; 1996 Feb; 148(2):405-13. PubMed ID: 8579104
[TBL] [Abstract][Full Text] [Related]
16. p53 and Ki-ras gene mutations in epithelial ovarian neoplasms.
Teneriello MG; Ebina M; Linnoila RI; Henry M; Nash JD; Park RC; Birrer MJ
Cancer Res; 1993 Jul; 53(13):3103-8. PubMed ID: 8319218
[TBL] [Abstract][Full Text] [Related]
17. p53 tumor suppressor gene mutation in early esophageal precancerous lesions and carcinoma among high-risk populations in Henan, China.
Gao H; Wang LD; Zhou Q; Hong JY; Huang TY; Yang CS
Cancer Res; 1994 Aug; 54(16):4342-6. PubMed ID: 8044781
[TBL] [Abstract][Full Text] [Related]
18. P53 expression, p53 and Ha-ras mutation and telomerase activation during nitrosamine-mediated hamster pouch carcinogenesis.
Chang KW; Sarraj S; Lin SC; Tsai PI; Solt D
Carcinogenesis; 2000 Jul; 21(7):1441-51. PubMed ID: 10874024
[TBL] [Abstract][Full Text] [Related]
19. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance.
Hsieh JS; Lin SR; Chang MY; Chen FM; Lu CY; Huang TJ; Huang YS; Huang CJ; Wang JY
Am Surg; 2005 Apr; 71(4):336-43. PubMed ID: 15943410
[TBL] [Abstract][Full Text] [Related]
20. Genetic evidence for the multicentric origin of synchronous multiple gastric carcinoma.
Kang GH; Kim CJ; Kim WH; Kang YK; Kim HO; Kim YI
Lab Invest; 1997 Mar; 76(3):407-17. PubMed ID: 9121123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
